Results 11 to 20 of about 7,091 (217)
International Spread of Multidrug-Resistant Rhodococcus equi. [PDF]
A multidrug-resistant clone of the animal and human pathogen Rhodococcus equi, MDR-RE 2287, has been circulating among equine farms in the United States since the 2000s. We report the detection of MDR-RE 2287 outside the United States. Our finding highlights the risk for MDR-RE spreading internationally with horse movements.
Val-Calvo J +9 more
europepmc +5 more sources
Rhodococcus equi: A pathogen in immunocompetent patients
Rhodococcus equi is an uncommon human pathogen known to cause lung infections in immunocompromised patients. We report two cases of Rhodococcus infections in immunocompetent individuals, who were treated successfully.
Meena Dias +3 more
doaj +3 more sources
<i>Rhodococcus parequi</i> sp. nov., a new species isolated from equine farm soil closely related to the pathogen <i>Rhodococcus equi</i>. [PDF]
We present the description of the new species, Rhodococcus parequi, found during phylogenomic investigations of a global collection of strains identified as Rhodococcus(Prescottella) equi.
Vazquez-Boland JA +6 more
europepmc +3 more sources
Whole-genome sequencing and pathogenicity analysis of Rhodococcus equi isolated in horses [PDF]
Background Rhodococcus equi (R. equi) is a Gram-positive zoonotic pathogen that frequently leads to illness and death in young horses (foals). This study presents the complete genome sequence of R. equi strain BJ13, which was isolated from a thoroughbred
Bin Hu +11 more
doaj +2 more sources
Is Rifampin (Rifampicin) Essential for the Treatment of Rhodococcus equi Infections in Foals? A Critical Review of the Role of Rifampin. [PDF]
ABSTRACT Rifampin is an enigma among antimicrobials. Blood and tissue compartment concentrations are a “moving target” along the treatment course due to the complex pharmacodynamic interactions within the body. Rifampin concomitant therapies are for the prevention and treatment of Rhodococcus equi infection in foals, for nearly 40 years.
Baptiste KE +4 more
europepmc +2 more sources
In the present study, the research work was carried out during June 2018 to March 2019 at ICAR-NRCE-EPC (Indian Council of Agricultural Research, National Research Centre on Equines, Equine Production Campus), Jorbeer, Bikaner (Rajasthan), India.
Lalit Kumar +5 more
doaj +1 more source
Rhodococcus equi is an important cause of subacute or chronic abscessating bronchopneumonia of foals up to 3-5 months of age. It shares the lipid-rich cell wall envelope characteristic of the mycolata, including Mycobacterium tuberculosis, as well as the ability of pathogenic members of this group to survive within macrophages.
Meijer, Wim, Prescott, John
openaire +3 more sources
Protective immune response against Rhodococcus equi: An innate immunity-focused review. [PDF]
Abstract Rhodococcus equi causes pyogranulomatous pneumonia in foals and immunocompromised people. Despite decades of research efforts, no vaccine is available against this common cause of disease and death in foals. The purpose of this narrative review is to summarise the current understanding of interactions between R. equi and the host innate immune
da Silveira BP +4 more
europepmc +2 more sources
RESUMO Rhodococcus equi é uma importante causa de broncopneumonia em potros com menos de seis meses de idade, sendo responsável pela mortalidade de eqüinos no mundo inteiro. É um microrganismo intracelular capaz de sobreviver e se multiplicar no interior de macrófagos.
Krewer, C.C. +3 more
openaire +3 more sources
Rhodococcus equi é um importante agente de infecções zoonóticas, podendo causar sérias infecções em humanos, principalmente em pacientes imunocomprometidos.
Carina Secchi +4 more
doaj +1 more source

